Lagundi Leaf Shipment Adulterated with Mint
A DOH-licensed herbal manufacturer in Laguna is producing lagundi (Vitex negundo) syrup. The warehouse receives 200 kg of dried leaves from a new supplier in Mindoro. The certificate of analysis states 100% Vitex negundo and 'passes identity.' During incoming inspection, the QC pharmacist notices that the leaves are darker than the authenticated reference, have a strong menthol-like odor, and include some simple, opposite leaves with square stems. The supplier's price is 30% below the usual cost. The plant has a TLC bench, authenticated Vitex negundo leaf reference, menthol and peppermint oil reference standards, and a microscope. Production is scheduled in 48 hours; the batch is needed to fill a hospital order. The manufacturer's SOP requires identity confirmation before release to production.
1. Propose an identity and purity testing scheme to determine whether the shipment is adulterated with Mentha or peppermint, using only the available equipment.
Read the worked answer
Use a three-level scheme. Macroscopic: compare with authenticated Vitex negundo-digitately compound leaves with 3–5 lanceolate, serrate leaflets, grayish beneath, characteristic odor; Mentha leaves are simple, opposite, serrate, with square stems and a strong menthol odor. Microscopic: look for Mentha labiate-family features such as square stem, glandular peltate trichomes, and oil glands, and compare with Vitex reference. TLC: extract the suspect leaves and references with methanol or ethyl acetate; spot on silica gel; develop in a suitable solvent; visualize under UV and with vanillin-sulfuric acid or anisaldehyde reagent. Compare Rf values with the authenticated Vitex marker and with menthol or peppermint oil. A menthol spot plus the macroscopic and microscopic findings is sufficient to confirm adulteration; TLC is not a quantitative assay.
2. What disposition decision is defensible if the mint odor and leaf morphology are confirmed, and what should be done with the 48-hour production schedule?
Read the worked answer
Reject the shipment. Adulteration with Mentha is a quality defect, not a cosmetic issue: it changes the active marker profile, may introduce allergens or irritants, and makes the finished syrup's identity and label false. Do not blend it with good stock to dilute the mint; that would be deliberate adulteration and would invalidate the batch. Do not use it to meet the 48-hour hospital order. Quarantine and segregate the 200 kg, document the rejection, notify the supplier in writing, and request replacement from a qualified supplier. Delay the production schedule and inform the hospital order contact; a short delay is preferable to releasing a misbranded herbal medicine. If any finished product was already made from the suspect lot, quarantine it and assess for recall.
3. What documentation and supplier-qualification actions should follow?
Read the worked answer
Open a deviation and supplier nonconformance report; retain samples and photographs; attach the CoA, inspection record, TLC plate, and microscopic findings. Require the supplier's root-cause investigation and corrective action; suspend the supplier pending re-qualification and audit. Update the incoming SOP to include mandatory odor, macroscopic, and TLC identity screening for every herbal lot, with trained second-person verification. Train warehouse and QC staff on Mentha and other common adulterants. Review other suppliers and lots, and keep the rejection record for FDA inspection.